ABSTRACT P2X 7 receptors are distinct from other ATP-gated P2X receptors in that they are potently inhibited by submicromolar concentrations of zinc and copper. The molecular basis for the strong functional inhibition by zinc and copper at this purinergic ionotropic receptor is controversial. We hypothesized that it involves a direct interaction of zinc and copper with residues in the ectodomain of the P2X 7 receptor. Fourteen potential metal interacting residues are conserved in the ectodomain of all mammalian P2X 7 receptors, none of which is homologous to previously identified sites in other P2X receptors shown to be important for functional potentiation by zinc. We introduced alanine substitutions into each of these residues, expressed wild-type and mutated receptors in human embryonic kidney 293 cells, and recorded resulting ATP and BzATP-evoked membrane currents. Agonist concentration-response curves were similar for all 12 functional mutant receptors. Alanine substitution at His 62 or Asp 197 strongly attenuated both zinc and copper inhibition, and the double mutant [H62A/D197A] mutant receptor was virtually insensitive to inhibition by zinc or copper. Thus, we conclude that zinc and copper inhibition is due to a direct interaction of these divalent cations with ectodomain residues of the P2X 7 receptor, primarily involving combined interaction with His 62 and Asp 197 residues.
wild-type and mutated receptors in human embryonic kidney 293 cells, and recorded resulting ATP and BzATP-evoked membrane currents. Agonist concentration-response curves were similar for all 12 functional mutant receptors. Alanine substitution at His 62 or Asp 197 strongly attenuated both zinc and copper inhibition, and the double mutant [H62A/D197A] mutant receptor was virtually insensitive to inhibition by zinc or copper. Thus, we conclude that zinc and copper inhibition is due to a direct interaction of these divalent cations with ectodomain residues of the P2X 7 receptor, primarily involving combined interaction with His 62 and Asp 197 residues.
The P2X 7 receptor (previously termed P2Z) is the last member (Surprenant et al., 1996) of the ATP-gated P2X receptor family and is found primarily on hematopoietic lineage cells, such as lymphocytes, monocytes, and macrophages, as well as brain microglial cells and astrocytes (North, 2002; Duan and Neary, 2006) . Studies using different approaches, including gene knockout, have underscored P2X 7 receptors as a crucial component in a diversity of biological processes, such as inflammation, elimination of intracellular pathogens, release of pro-inflammatory cytokines by macrophages, and release of neurotransmitters by astrocytes, and chronic inflammatory and neuropathic pain (e.g., Lammas et al., 1997; Solle et al., 2001; Chessell et al., 2005; Duan and Neary, 2006; Ferrari et al., 2006) . P2X 7 receptors show several unique functional features that differ strikingly from those of other members of the P2X receptor family (North, 2002) . P2X 7 receptors display remarkable functional plasticity; brief activation opens small cation permeable channels, whereas prolonged stimulation induces formation of "large molecule" permissive pores, rapid membrane and mitochondrial morphological changes, cytoskeletal rearrangement, and eventual cell death (Surprenant et al., 1996; North, 2002; Morelli et al., 2003) . The most upstream signaling event consequent to the P2X 7 receptor activation, the ionic current, also shows properties uniquely different from those of other P2X receptors. Currents are activated by submillimolar concentrations of ATP, which are 10 to 100 times higher than those required for activation of other P2X receptors. Furthermore, P2X 7 receptors are potently inhibited by submicromolar concentrations of zinc and copper, whereas other P2X receptors are strongly potentiated or unaffected (Wildman et al., 1998 (Wildman et al., , 1999a Xiong et al., 1999; Acuñ a-Castillo et al., 2000; Clyne et al., 2002; Lorca et al., 2005) . P2X 7 receptors are also substantially inhibited by magnesium and calcium, albeit with much less potency than zinc and copper. Earlier studies examining the effects of calcium and magnesium have led to the view that ATP 4Ϫ is the effective agonist form of ATP and these divalent cations inhibit the P2X 7 receptors by reducing the effective agonist concentrations (Cockcroft and Gomperts, 1979 ). This view is still prevailing and implied in the inhibition by other divalent cations such as zinc and copper (North, 2002) . Our previous indirect evidence demonstrates that the divalent cation that induces inhibition of P2X 7 currents is due primarily to direct binding to and subsequent allosteric modulation of the P2X 7 receptor (Virginio et al., 1997) .
Histidine, cysteine, lysine, aspartic acid, and glutamic acid residues are all known to be capable of coordinating zinc inhibition/potentiation of different ion channels, such as GABA C receptors (Wang et al., 1995) , glycine receptors (Laube et al., 2000) , N-methyl-D-aspartate receptors (Paoletti et al., 2000) , and acid-sensing ion channels (Chu et al., 2004) . Sequence analysis of the ectodomain of the seven P2X receptor subunits led us to the identification of 14 potential zinc interacting residues that are conserved in mouse, rat, and human P2X 7 receptors but not the other P2X receptor family members. We introduced alanine substitution by site-directed mutagenesis into these 14 positions in the rat P2X 7 receptor and found that mutation of His 62 or Asp 197 residues strongly attenuated the inhibition by zinc and copper. Thus, the present study provides direct evidence supporting the view that the potent functional inhibition of the P2X 7 receptor by zinc and copper results primarily from an interaction with the receptor, in which His 62 and Asp 197 residues are critical.
Materials and Methods
Cell and Molecular Biology. Human embryonic kidney (HEK293) cells were cultured and transfected with plasmids as described previously (Jiang et al., 2001 ). Wild-type and mutant rat P2X 7 receptors were engineered to contain a C-terminal EYMPME epitope (EE tag). Tagging had no detectable effect on the functional properties of wild-type P2X 7 receptors (L.-H. Jiang and A. Surprenant, unpublished data) . Alanine substitution was introduced by site-directed mutagenesis and confirmed by sequencing.
Electrophysiological Recording. Whole-cell recordings were carried out using an Axopatch 200B (Molecular Devices, Sunnyvale, CA) or EPC10 (HEKA, Lambrecht/Pfalz, Germany) amplifier at room temperature as described previously (Jiang et al., 2001) . Cells were held at Ϫ60 mV. Patch pipettes were fabricated from borosilicate glass capillaries with a resistance of 4 to 6 M⍀. Standard external solution contained 147 mM NaCl, 2 mM KCl, 1 mM MgCl 2 , 2 mM CaCl 2 , 10 mM HEPES, and 13 mM glucose. Intracellular solution contained 145 mM NaCl, 10 mM EGTA, and 10 mM HEPES. Copper chloride and zinc sulfate salts were dissolved in standard external solution. Application of the agonists, zinc and copper was carried out via a rapid solution changer RSC-160 system (Bio-Logic Science Instruments, Claix, France), which has limitations in studying very fast kinetics (Spelta et al., 2002) , possibly contributing to the variable rebound currents. All the chemicals were purchased commercially (Sigma, St. Louis, MO).
Immunocytochemistry. Transfected cells were stained as described previously (Jiang et al., 2001 ) using mouse primary anti-EE antibody at a dilution of 1:1000 (BAbCO, Richmond, CA) and secondary fluorescein isothiocyanate-conjugated anti-mouse IgG antibody at a dilution of 1:200 (Sigma), or using rabbit anti-EE antibody at a dilution of 1:1000 (Bethyl Laboratories, Montgomery, TX) and secondary Alexa Fluor 488 anti-rabbit IgG antibody at a dilution of 1:2000 (Invitrogen, Carlsbad, CA). The images were captured using a Zeiss AxioVert 200M confocal microscope and LSM510 META software (Carl Zeiss GmbH, Jena, Germany).
Data Analysis. All data, where appropriate, are presented as mean Ϯ S.E.M. The EC 50 values for the agonists BzATP and ATP were determined by least-squares curve fitting to the Hill equation:
nH ], where I is the current as a fraction of the maximum (I max ), [A] is the agonist concentration, and n H is the Hill coefficient. Likewise, the IC 50 values for the inhibitors zinc and copper were derived by fitting to
nH ], where I is the current as a fraction of the control current (I 0 ) in the absence of the inhibitors under examination and [B] is the inhibitor concentration. It is noteworthy that in the present study (except Fig. 1C ), zinc or copper was coapplied with agonists for 4 s, and in most experiments, the inhibition occurred quickly and reached steady state by the end of the 4-s application. Figures show the curves fitted to the mean of all experiments. Curve fit was done using Origin software (OriginLab Corp, Northampton, MA). Statistical analysis was carried out using Student's t test.
Results
Zinc Inhibition of BzATP-Evoked Currents at the Wild-Type P2X 7 Receptor. We used BzATP at 30 M, which evoked 30 to 50% of maximum current, and three A and B, representative BzATP-evoked currents in the presence of increasing concentrations of zinc. Note that there were robust rebound currents accompanying simultaneous washout of zinc and BzATP, as indicated by the arrows (the first protocol, A), which were absent in washout of BzATP in the persistent presence of zinc (the second protocol, B). C, zinc concentration-current response curves from all protocols as shown in A and B and described in text (n ϭ 3-8 for each point). F, data from the first protocol (IC 50 ϭ 4.6 Ϯ 0.9 M, n ϭ 8); f, data from the second protocol (IC 50 ϭ 5.9 Ϯ 1.2 M, n ϭ 4); OE, data from preapplication of zinc (IC 50 ϭ 5.6 Ϯ 1.4 M, n ϭ 4). These values were not significantly different from each other. distinct protocols to examine zinc inhibition of the BzATPevoked currents: simultaneous application and washout of agonist and zinc (Fig. 1A) , simultaneous application of agonist/zinc with sustained presence of zinc upon washout of BzATP (Fig. 1B) , or preapplication of zinc for 30 to 90 s followed by either of the former protocols (Fig. 1C) . The zinc inhibition curves were not significantly different using any of these protocols (IC 50 ϭ 4.6 Ϯ 0.9 ⌴, n ϭ 8; 5.9 Ϯ 1.2 M, n ϭ 4, and 5.6 Ϯ 1.4 M, n ϭ 4, respectively). It is noteworthy that we observed rebound currents upon simultaneous washout of agonist and zinc irrespective of the duration of preapplication of zinc (Fig. 1A) . These rebound currents were particularly prominent at high concentrations of zinc but were never observed upon washing agonist in the persistent presence of zinc (Fig. 1B) . No quantitative characterization of the rebound currents was attempted because there was significant variation in their amplitude that was probably due to the limited solution exchange rate of the system (see Materials and Methods). However, the presence of rebound currents upon simultaneous agonist/antagonist washout suggests that they result from the faster dissociation of zinc from its binding site than that of BzATP from its binding site. This further supports our hypothesis that zinc interacts directly with sites on the receptor protein rather than acting by chelating free ATP 4Ϫ . We thus turned to site-directed mutagenesis studies to seek direct evidence to corroborate this view.
Effects of Alanine Substitution on Functional Expression. Sequence analysis of the ectodomains of the seven P2X receptor subunits identified 14 potential interacting residues (five histidines, three glutamic acids, two aspartic acids, and four lysines) uniquely located in the ectodomain of the P2X 7 receptor but not P2X 1-6 receptors (Supplemental Fig. 1 ). This analysis was based on the discriminating actions at the P2X 7 receptor versus other P2X receptors and the known roles of histidine, cysteine, lysine, aspartic acid, and glutamic acid in zinc-mediated inhibition/potentiation of several ion channels (see Introduction). We substituted the individual residues with alanine, expressed the resultant mutant receptors in HEK293 cells, and measured the BzATP-evoked currents by patch clamp recording. The current amplitudes to maximum concentration of BzATP were not significantly different from wild-type currents at 11 of the mutant receptors (Table 1) . Either no currents or minimal (Ͻ 50 pA) currents were recorded at the P2X 7 mutant receptors [K54A] and [D156A], and immunostaining using an anti-EE epitope Ab showed significantly reduced membrane localization (Supplemental Fig. 2) . Therefore, these mutant receptors were not further investigated. The [H201A] mutant receptor showed significantly lower maximum current amplitudes (4-fold lower) without a significant shift in the agonist EC 50 (Table 1) . Of the 12 functional mutant receptors examined in this study, only one, [K145A], showed a significantly different BzATP EC 50 value, which was shifted to the right by approximately 4-fold (Table 1) . These results suggest that alanine substitution at all sites introduced minimal global conformational changes.
Effects of Zinc. First, we examined the wild-type and 12 functional mutant channel currents elicited by 30 M BzATP (producing ϳ20-50% of the maximum current as shown in Supplemental Fig. 3 , except [K145A] at which 200 M BzATP was used). We used this concentration of BzATP to minimize the potential functional regulation by endogenous P2Y receptors (see Discussion). Furthermore, we used 30 M zinc (resulting in nearly maximum inhibition) in the presence of BzATP to ask which residues, upon substitution with alanine, would give rise to pronounced reduction or loss of zinc inhibition. No significant differences in zinc inhibition of the BzATP-evoked currents were observed at 10 of the 12 mutant receptors examined (Fig. 2) ; however, we noted that zinc inhibition at the [H201A] mutant receptor showed much greater variability compared with the other receptors (Fig.  2B) . Upon simultaneous washout of BzATP and zinc, rebound currents continued to be present at all of these mutant receptors and were not qualitatively different from those observed for the wild-type receptor. In contrast, zinc inhibition of BzATP-evoked currents was strongly attenuated (by 65-85%) at both [H62A] and [D197A] mutant receptors (Fig.  2) (Fig. 3) . IC 50 values in these experiments were 6.6 Ϯ 0.7 M (n ϭ 15), 5.9 Ϯ 1.4 M (n ϭ 4), 52 Ϯ 2.6 M (n ϭ 10), and 171 Ϯ 27 M (n ϭ 7) for the wild-type receptor and [H201A], [D197A], and [H62A] mutant receptors, respectively. We also generated a P2X 7 receptor double mutant, [H62A/D197A], and found that the maximum current amplitude was reduced approximately 3-fold; however, the BzATP concentration response curve was shifted significantly to the left at this mutant receptor, resulting in an approximately 4-fold decrease in BzATP EC 50 value (Table 1) . In contrast to these relatively modest alterations in receptor function, the [H62A/D197A] double mutant receptor was virtually resistant to inhibition by zinc at concentrations up to 100 M (Fig.  3) . In addition, no rebound currents were observed upon simultaneous washout of BzATP and zinc for the [H62A] and [H62A/D197A] mutant receptors; however, rebound currents were reduced, but not abolished, for the [D197A] mutant receptor ( Figs. 2A and 3A) .
Effects of Copper. Copper also inhibits P2X 7 receptors with even greater potency than zinc (Virginio et al., 1997) . Here, we also examined copper inhibition of BzATP-evoked currents for the wild-type receptor and 12 functional mutant receptors, using protocols similar to those for zinc inhibition (i.e., 30 M BzATP and 10 M copper, a concentration having nearly maximum inhibition). We observed little or no re- 2 M (n ϭ 13), 12 Ϯ 1.6 M (n ϭ 8), 17 Ϯ 1.6 M (n ϭ 8), and 114 Ϯ 25 M (n ϭ 9) respectively (Fig. 5) .
Effects of Zinc and Copper on ATP-Evoked Currents.
Finally, we repeated these experiments using 1 mM ATP (producing ϳ20-50% of the maximum current of the wildtype and mutant receptors) as the agonist. It was noted that both zinc and copper were slightly less potent in inhibiting the wild-type P2X 7 receptors activated by ATP than by BzATP; the IC 50 values for zinc (19 Ϯ 1.1 M, n ϭ 4) and copper (6.4 Ϯ 1.9 M, n ϭ 4) were 2-3 fold greater than those observed with BzATP as the agonist. The concentrations of zinc (100 M) and copper (10 M) used in these experiments resulted in inhibition of the wild-type receptor currents by approximately 70%. The offset kinetics of ATP at the P2X 7 receptor were significantly faster than those observed with BzATP, most likely because BzATP has a higher affinity for this receptor. We also observed no rebound current upon simultaneous washout of ATP with zinc or copper at the wild-type or any of the mutant receptors (Fig. 6) . Similar to the results obtained using BzATP as a agonist, we found that zinc and copper inhibition of ATP-evoked currents was potently attenuated or abolished for the [H62A], [D197A], and [H62A/D197A] P2X 7 mutant receptors (Fig. 6 ). In addition, there was a small but nonetheless significant attenuation of (Fig. 6 ) that was not observed when BzATP was used as the agonist (compare Figs. 2 and 4) .
Discussion
The key finding from this study is the identification of residues His 62 and Asp 197 , located in the ectodomain of the P2X 7 receptor, that are critical for inhibition by the divalent cations zinc and copper. This is of much conceptual significance, because it provides direct evidence against the longstanding view that divalent cation inhibition of P2X 7 receptors results from chelation of ATP 4Ϫ , which is considered to be the effective agonist (North, 2002) . Indeed, single or combined mutation of His 62 and Asp 197 results in minimal effects on agonist sensitivity (Table 1 ) but strongly reduces zinc and copper inhibition, which quite conclusively excludes such an interpretation and substantiates the idea that direct binding is the primary mechanism underlying the inhibition of the P2X 7 receptor by divalent cations. The rebound currents recorded upon simultaneous washout of BzATP and zinc lend further support. Copper inhibition (IC 50 ϳ 2-5 M) was more potent than zinc inhibition (IC 50 ϳ 5-10 M), and rebound currents were observed only upon washout of zinc with BzATP but not ATP. The simplest explanation could be that the rebound currents depend upon the relative dissociation rate of the divalent cation and the agonist used. Thus, if the dissociation rate of ATP is Ͼ BzATP and that of zinc Ͼ BzATP Ն copper, rebound currents could occur only with the BzATP/zinc combination.
Zinc and copper in submicromolar concentrations have either opposite effects or no actions at other P2X receptors. For example, zinc potently facilitates the P2X 2 and P2X 4 receptor currents (see Introduction). Similar mutational analysis by Nagaya et al. (2005) in the ectodomain of P2X 2 receptors identified His 120 and His 213 as the key residues mediating zinc facilitation of P2X 2 receptor. Subsequently, a series of elegant experiments on concatenated P2X 2 trimers convincingly demonstrated that these two residues are located closely at the interface between subunits and form an intersubunit zinc binding site. There is no information regarding how close His 62 and Asp 197 residues are in the P2X 7 receptor, but similar approaches may be expected to determine whether these two key residues form interior intrasubunit zinc/copper binding sites. It is noteworthy that our functional characterization (Table 1) showed that alanine substitution of both residues together ([H62A/D197A] double mutant), but not individually, resulted in a significant increase in the agonist sensitivity. This is reminiscent of the mutational effects on the close apposition and direct interaction between the N-terminal ligand binding domain and the extracellular loops between transmembrane segments in the pore forming domain, which underlie the gating of the GABA A (Kash et al., 2003) and nACh receptors (Lee and Sine, 2005) . Although the mutational effects on agonist sensitivity are not fully understood, one possibility is that His 62 and Asp 197 may be closely positioned. His 62 is located between Lys 64 , the critical residue for P2X 7 receptor activation (Wilkinson et al., 2006) , and the first transmembrane domain, which is also implicated in channel gating (Jiang et al., 2001 ). An alternative explanation is that replacement of both His 62 and Asp 197 with alanine (a residue that contains a small side chain) may facilitate, to some extent, the channel gating. Consistent with this idea, occupation by divalent cations would disfavor channel gating and thereby results in a rightward shift and suppression of maximal receptor responses in the agonist concentration response curves as previously observed (Virginio et al., 1997) . Finally, the present study has also shown a critical role of the nonhistidine residue (Asp 197 ) in coordinating zinc and copper inhibition of the P2X 7 receptor, similar to zinc inhibition of the N-methyl-D-aspartate receptor (Paoletti et al., 2000) .
We observed modest, but significant differences depending on the agonists used: first, zinc and copper were 2-to 3-fold more potent at inhibiting BzATP-evoked currents than ATPevoked currents. Second, when BzATP was used to evoke currents, only single and double mutations of His 62 and Asp 197 resulted in significant attenuation of zinc and copper inhibition. These mutant receptors also exhibited the strongest attenuation of zinc and copper inhibition when ATP was the agonist, but we also observed significant attenuation at the [H201A] and [H267A] mutant receptors (compare Figs. 2B, 4B, and 7). We have identified two residues in the ectodomain that could account for the differential agonist (BzATP versus ATP) sensitivity at the P2X 7 receptor. We demonstrated that Lys 127 and Asn 284 together are required to maintain BzATP potency, whereas Asn 284 alone is involved in ATP potency. We therefore suggest that these findings may indicate overlapping but distinct regions of the P2X 7 receptor that bind BzATP and ATP (Young et al., 2007) . If binding of BzATP involves residues in addition to those required for ATP binding, it is reasonable to imagine a similar overlapping but distinct binding of divalent cations in the presence of each of these agonists. In any event, the actions of zinc and copper share the same two key residues (His 62 and Asp 197 ), both of which are required to inhibit currents evoked by either agonist. Another possible contribution to the modest agonist-dependent difference seen here is the potential regulation of the P2X 7 receptor by the endogenous P2Y receptors (Schachter et al., 1997) as shown for the P2X 1 receptor (Vial et al., 2004) . However, such an effect should be minimal when BzATP is used (Wilson et al., 2002) .
During the preparation of the present study, an article by Acuñ a-Castillo et al. (2007) appeared in which they examined the role of histidine residues in zinc and copper inhibition of ATP-evoked rat P2X 7 receptor currents in Xenopus laevis oocytes expressing single alanine mutant receptors. In agreement with our findings, this group also observed no significant effects on agonist sensitivity by mutating the histidine residues and reached the same conclusion that zinc and copper inhibition of the P2X 7 receptor has little to do with changes in the active form of the agonist. However, their results differ considerably from ours in terms of the contribution these residues make. Acuñ a-Castillo et al. (2007) showed that the [H201] and [H267A] mutant receptors had either a significant reduction in or loss of inhibition by copper, whereas the [H219A] and [H267A] mutant receptors were both insensitive to inhibition by zinc. We also demonstrated a reduced zinc or copper inhibition of the [H201A] and [H267A] mutant receptors when ATP was used as the agonist, but clearly the reduction was far less pronounced compared with [H62A] and [D197A] mutants (the latter mutant was not studied by Acuñ a-Castillo et al., 2007) (Fig. 6) . The inhibition became variable and insignificantly different from the wild-type receptor when BzATP was the agonist (Fig. 2B) , probably because of the relatively higher potency of zinc and copper (see Results). The most surprising difference between the two studies is that we found the most prominent decrease in zinc and copper inhibition of P2X 7 receptor currents at the [H62A] mutant receptor, regardless of whether we used BzATP (Figs. 2-5) or ATP (Fig. 6 ), whereas Acuñ a- Castillo et al. (2007) observed no effects evoked by ATP. Inconsistent results have been noted for P2X 7 receptors expressed in mammalian cells and oocytes. The most noticeable difference is that just as in native P2X 7 receptor expressing cells, formation of the large dye uptake pore was persistently observed when the P2X 7 receptors were expressed in mammalian cells (e.g., Surprenant et al., 1996) but not in oocytes (Petrou et al., 1997; Klapperstü ck et al., 2000) . In addition, loss of function associated with a naturally occurring mutation E496A in monocytes and lymphocytes (Gu et al., 2001) was confirmed in HEK293 cells (Cabrini et al., 2005) . However, the [E496A] mutant receptor was functional and insignificantly differed from the wild-type receptor in oocytes as well as in HEK293 cells in another study (Boldt et al., 2003) . Thus, utilization of the expression cells and in particular different cells (mammalian cell versus oocyte) may contribute to the discrepancy observed in the different studies.
Inhibition of P2X 7 receptors by zinc and copper has significant physiological relevance. For example, P2X 7 receptors are expressed in brain astrocytes and glial cells where they are increasingly known to engage in neural signaling processes such as neurotransmitter release (Duan and Neary, 2006) . Local concentrations of zinc and copper released from nerve terminals are in the range of 10 to 100 M (Kardos et al., 1989; Li et al., 2001 ) and can easily reach astrocytes and glial cells, which are in close vicinity and thus inhibit P2X 7 receptors. P2X 7 receptors are highly expressed in immune cells and important to the physiology and pathology of these cells (see Introduction). Under conditions of infection and/or inflammation, copper is found at micromolar concentrations and is essential for both T-cell proliferation and the ability of neutrophils to generate superoxide to kill ingested microorganisms (Percival, 1998) . The present study has revealed, at the molecular level, how zinc and copper modulate the P2X 7 receptor.
In summary, we have provided direct evidence showing that zinc and copper inhibition is due to a direct interaction with ectodomain residues of the P2X 7 receptor, primarily involving combined interaction with His 62 and Asp 197 . The present study enhances our understanding of how this multifunctional ionotropic purinergic receptor can be activated by agonist, and in particular modulated by trace metals.
